These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 22643101)
21. Wound-healing factors secreted by epidermal keratinocytes and dermal fibroblasts in skin substitutes. Spiekstra SW; Breetveld M; Rustemeyer T; Scheper RJ; Gibbs S Wound Repair Regen; 2007; 15(5):708-17. PubMed ID: 17971017 [TBL] [Abstract][Full Text] [Related]
22. Evaluation of cultured human dermal- and dermo-epidermal substitutes focusing on extracellular matrix components: Comparison of protein and RNA analysis. Oostendorp C; Meyer S; Sobrio M; van Arendonk J; Reichmann E; Daamen WF; van Kuppevelt TH Burns; 2017 May; 43(3):520-530. PubMed ID: 28041746 [TBL] [Abstract][Full Text] [Related]
23. A novel hydrogel-collagen composite improves functionality of an injectable extracellular matrix. Hartwell R; Leung V; Chavez-Munoz C; Nabai L; Yang H; Ko F; Ghahary A Acta Biomater; 2011 Aug; 7(8):3060-9. PubMed ID: 21569870 [TBL] [Abstract][Full Text] [Related]
25. Fibroblast heterogeneity: more than skin deep. Sorrell JM; Caplan AI J Cell Sci; 2004 Feb; 117(Pt 5):667-75. PubMed ID: 14754903 [TBL] [Abstract][Full Text] [Related]
26. Reduced contraction of skin equivalent engineered using cell sheets cultured in 3D matrices. Ng KW; Hutmacher DW Biomaterials; 2006 Sep; 27(26):4591-8. PubMed ID: 16720038 [TBL] [Abstract][Full Text] [Related]
27. [Employment of current results of tissue engineering in the development of skin substitutes]. Dragúňová J; Koller J; Cucorová V Cas Lek Cesk; 2012; 151(6):286-93. PubMed ID: 22913760 [TBL] [Abstract][Full Text] [Related]
28. The effect of gelatin-chondroitin sulfate-hyaluronic acid skin substitute on wound healing in SCID mice. Wang TW; Sun JS; Wu HC; Tsuang YH; Wang WH; Lin FH Biomaterials; 2006 Nov; 27(33):5689-97. PubMed ID: 16908060 [TBL] [Abstract][Full Text] [Related]
29. Modulation of scar tissue formation using different dermal regeneration templates in the treatment of experimental full-thickness wounds. Druecke D; Lamme EN; Hermann S; Pieper J; May PS; Steinau HU; Steinstraesser L Wound Repair Regen; 2004; 12(5):518-27. PubMed ID: 15453834 [TBL] [Abstract][Full Text] [Related]
30. Replacement of animal-derived collagen matrix by human fibroblast-derived dermal matrix for human skin equivalent products. El Ghalbzouri A; Commandeur S; Rietveld MH; Mulder AA; Willemze R Biomaterials; 2009 Jan; 30(1):71-8. PubMed ID: 18838164 [TBL] [Abstract][Full Text] [Related]
31. Understanding experimental biology of skin equivalent: from laboratory to clinical use in patients with burns and chronic wounds. Ehrlich HP Am J Surg; 2004 May; 187(5A):29S-33S. PubMed ID: 15147989 [TBL] [Abstract][Full Text] [Related]
32. IFATS collection: Using human adipose-derived stem/stromal cells for the production of new skin substitutes. Trottier V; Marceau-Fortier G; Germain L; Vincent C; Fradette J Stem Cells; 2008 Oct; 26(10):2713-23. PubMed ID: 18617689 [TBL] [Abstract][Full Text] [Related]
33. Tissue response and wound healing after placement of two types of bioengineered grafts containing vital cells in submucosal maxillary pouches: an experimental pilot study in rabbits. Bornstein MM; Reichart PA; Buser D; Bosshardt DD Int J Oral Maxillofac Implants; 2011; 26(4):768-75. PubMed ID: 21841986 [TBL] [Abstract][Full Text] [Related]
34. Clinical application of autologous three-cellular cultured skin substitutes based on esterified hyaluronic acid scaffold: our experience. Scuderi N; Anniboletti T; Carlesimo B; Onesti MG In Vivo; 2009; 23(6):991-1003. PubMed ID: 20023246 [TBL] [Abstract][Full Text] [Related]
35. Biological evaluation of collagen-chitosan scaffolds for dermis tissue engineering. Sun LP; Wang S; Zhang ZW; Wang XY; Zhang QQ Biomed Mater; 2009 Oct; 4(5):055008. PubMed ID: 19779250 [TBL] [Abstract][Full Text] [Related]
36. [Mechanisms and effects of biosynthesis and apoptosis in repair of full-thickness skin defect with collagen-chitosan dermal stent]. Xu SJ; Huang AB; Ma L; Teng JY; Gao CY; Zhang ZL; Ni YD; Ye S; Wang YG Zhonghua Zheng Xing Wai Ke Za Zhi; 2009 May; 25(3):208-12. PubMed ID: 19803205 [TBL] [Abstract][Full Text] [Related]
37. [Porous matrix and primary-cell culture: a shared concept for skin and cornea tissue engineering]. Auxenfans C; Builles N; Andre V; Lequeux C; Fievet A; Rose S; Braye FM; Fradette J; Janin-Manificat H; Nataf S; Burillon C; Damour O Pathol Biol (Paris); 2009 Jun; 57(4):290-8. PubMed ID: 18602223 [TBL] [Abstract][Full Text] [Related]
38. Wound-healing gene family expression differences between fetal and foreskin cells used for bioengineered skin substitutes. Hirt-Burri N; Scaletta C; Gerber S; Pioletti DP; Applegate LA Artif Organs; 2008 Jul; 32(7):509-18. PubMed ID: 18638304 [TBL] [Abstract][Full Text] [Related]
39. Modified plastic compression of collagen hydrogels provides an ideal matrix for clinically applicable skin substitutes. Braziulis E; Diezi M; Biedermann T; Pontiggia L; Schmucki M; Hartmann-Fritsch F; Luginbühl J; Schiestl C; Meuli M; Reichmann E Tissue Eng Part C Methods; 2012 Jun; 18(6):464-74. PubMed ID: 22195768 [TBL] [Abstract][Full Text] [Related]
40. [Reconstruction of extensive soft tissue loss by transplantation of dermal and epidermal equivalents]. Hollander DA; Gutt CN; Falk S; Windolf J; Erli HJ; Paar O Zentralbl Chir; 2004 Jan; 129(1):29-36. PubMed ID: 15011109 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]